These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 17581492

  • 1. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J.
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [Abstract] [Full Text] [Related]

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR, Hydo LJ, Shou J, Barie PS.
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia.
    Heyland DK, Dodek P, Muscedere J, Day A, Cook D, Canadian Critical Care Trials Group.
    Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545
    [Abstract] [Full Text] [Related]

  • 5. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.
    Rodríguez A, Mendia A, Sirvent JM, Barcenilla F, de la Torre-Prados MV, Solé-Violán J, Rello J, CAPUCI Study Group.
    Crit Care Med; 2007 Jun; 35(6):1493-8. PubMed ID: 17452932
    [Abstract] [Full Text] [Related]

  • 6. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A.
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
    Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J.
    Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of monotherapy in the treatment of Pseudomonas ventilator-associated pneumonia in patients with trauma.
    Magnotti LJ, Schroeppel TJ, Clement LP, Swanson JM, Bee TK, Maish GO, Minard G, Zarzaur BL, Fischer PE, Fabian TC, Croce MA.
    J Trauma; 2009 Apr; 66(4):1052-8; discussion 1058-9. PubMed ID: 19359914
    [Abstract] [Full Text] [Related]

  • 9. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
    Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanèse J, Martin C.
    Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL.
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D, Hilbert G, Vargas F, Valentino R, Bui N, Pereyre S, Bebear C, Bebear CM, Gbikpi-Benissan G.
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
    Eagye KJ, Nicolau DP, Kuti JL.
    Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
    [Abstract] [Full Text] [Related]

  • 16. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 17. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Deconinck L, Meybeck A, Patoz P, Van Grunderbeeck N, Boussekey N, Chiche A, Delannoy PY, Georges H, Leroy O.
    Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
    [Abstract] [Full Text] [Related]

  • 18. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis.
    Kuti EL, Patel AA, Coleman CI.
    J Crit Care; 2008 Mar; 23(1):91-100. PubMed ID: 18359426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.